These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16613564)

  • 1. Recombinant expression systems for allergen vaccines.
    Singh MB; Bhalla PL
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):53-9. PubMed ID: 16613564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant allergens for immunotherapy.
    Chapman MD; Smith AM; Vailes LD; Pomés A
    Allergy Asthma Proc; 2002; 23(1):5-8. PubMed ID: 11894735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches for new vaccines against allergy.
    Niederberger V; Valenta R
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant allergens for immunotherapy. Where do we stand?
    Niederberger V; Valenta R
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):549-54. PubMed ID: 15640698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified recombinant allergens for safer immunotherapy.
    Ferreira F; Briza P; Inführ D; Schmidt G; Wallner M; Wopfner N; Thalhamer J; Achatz G
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):5-14. PubMed ID: 16613559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered plant allergens with reduced anaphylactic activity.
    Singh MB; de Weerd N; Bhalla PL
    Int Arch Allergy Immunol; 1999 Jun; 119(2):75-85. PubMed ID: 10394098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide and Recombinant Allergen Vaccines for Food Allergy.
    Cook QS; Burks AW
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):162-171. PubMed ID: 29368278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
    Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression and production of plant allergens by molecular farming strategies.
    Obermeyer G; Gehwolf R; Sebesta W; Hamilton N; Gadermaier G; Ferreira F; Commandeur U; Fischer R; Bentrup FW
    Methods; 2004 Mar; 32(3):235-40. PubMed ID: 14962757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy: current and new therapeutic strategies.
    Rolland JM; Douglass J; O'Hehir RE
    Expert Opin Investig Drugs; 2000 Mar; 9(3):515-27. PubMed ID: 11060692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of two isoforms of Lep d 2, the major allergen of Lepidoglyphus destructor, in both prokaryotic and eukaryotic systems.
    Olsson S; van Hage-Hamsten M; Whitley P; Johansson E; Hoffman DR; Gafvelin G; Schmidt M
    Clin Exp Allergy; 1998 Aug; 28(8):984-91. PubMed ID: 9756203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
    Pree I; Reisinger J; Focke M; Vrtala S; Pauli G; van Hage M; Cromwell O; Gadermaier E; Egger C; Reider N; Horak F; Valenta R; Niederberger V
    J Immunol; 2007 Oct; 179(8):5309-16. PubMed ID: 17911617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
    Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
    Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.